Liver
This format aims to offer a basic course series for beginners, focusing on a different organ each year. This year, the topic of this six-hour course will be the liver and will feature three distinct sessions.
April 16-19 | Stockholm, Sweden
April 16-19 | Stockholm, Sweden
April 16-19 | Stockholm, Sweden
April 16-19 | Stockholm, Sweden
April 16-19 | Stockholm, Sweden
Basic course series
Learning objectives:
- To build a clinical practice in diagnostic and therapeutic image-guided liver intervention
- To select the best treatment option for a given clinical situation
- To discuss surgical, radiation, and medical oncology treatments at the tumour board and with referred patients
- To interact with the other physician in charge of cancer treatment to provide the best diagnostic and therapeutic option to the patient
BC 153 – Liver 1
Sunday, April 16, 17:00-19:00
Moderators: A. Denys (Lausanne/CH), P. Lucatelli (Rome/IT)
Imaging and biopsy of liver tumours: what an IO should know
A. Najafi (Winterthur/CH)
Anatomy of liver arteries: tips and tricks for catheterism
J. Bell (Manchester/GB)
Ablation tools for liver tumours: RFA, microwave, IRE, cryo, multipolar and monopolar
F. Veloso Gomes (Lisbon/PT)
Compounds for intra-arterial therapies: chemotherapy, lipiodol, beads and embolics
P. Lucatelli (Rome/IT)
BC 253 – Liver 2
Monday, April 17, 17:00-19:00
Moderators: A. Denys (Lausanne/CH), J. Bell (Manchester/GB)
Ablation of primary liver tumours: best indications and best technique
A. Najafi (Winterthur/CH)
TACE of HCC: how to deliver and how to manage the patient?
J. Bell (Manchester/GB)
Ablation of metastatic liver tumours: when and how?
F. Veloso Gomes (Lisbon/PT)
TACE of liver metastases: which patients and how to manage it
P. Lucatelli (Rome/IT)
BC 353 – Liver 3
Tuesday, April 18, 17:00-19:00
Moderators: A. Denys (Lausanne/CH), R. Lewandowski (Chicago, IL/US)
TACE and ablation complications: how to avoid, how to recognise and how to manage
M. Sone (Tokyo/JP)
Radioembolisation: current available tools and dosimetry
R.-T. Hoffmann (Dresden/DE)
TARE in HCC patients: good indications and good practice
E. Bozzi (Pisa/IT)
Radioembolisation out of HCC: CRC, iCC, melanoma and others…
R. Lewandowski (Chicago, IL/US)